N/A
Completed N=1,022
Testing the Helpfulness of 2 Decision Aids for Prostate Cancer
Source: ClinicalTrials.gov NCT00432601 ↗Enrolled (actual)
1,022
Serious AEs
0.0%
Results posted
Mar 2016
Primary outcomePrimary: Knowledge — 53; 48 percentage correct on a 12 item scale
Summary
The purpose of this study is to test different methods for communicating information about prostate cancer treatment to men. The investigators are studying how best to present information so men can make informed decisions about what prostate cancer treatment to undergo.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Knowledge |
53; 48 | — |
Eligibility Criteria
Inclusion Criteria
Men undergoing a prostate cancer biopsy at Ann Arbor, Durham, San Francisco, or Pittsburgh VAs. Additional inclusion criteria includes ability to speak English, provide informed consent, and have a PSA < 20.
Exclusion Criteria
Prior history of prostate cancer
Data sourced from ClinicalTrials.gov (NCT00432601). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.